John Li

Director - RNA Drug Substance at Capstan Therapeutics

Speaker

John J. Li is the Director of RNA Drug Substance at Capstan Therapeutics where he focuses on process development, technology innovation and CMC for RNA therapeutics. John has broad technical experience in platform process design with respect to various drug modalities such as Monoclonal antibody, Antibody variants, ADC, AAV/Lentivirus, Plasmid DNA, and recombinant proteins.. He holds a PhD in Structural Biology from the University of Toronto, Canada, where he studied protein kinase catalytic mechanisms by x-ray crystallography.